Wheeler, Deric L.

Understanding resistance to EGFR inhibitors—impact on future treatment strategies

Wheeler, D. L., Dunn, E. F., & Harari, P. M. (2010) · Nature Reviews Clinical Oncology

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 683

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

Wheeler, D. L., Huang, S., Kruser, T. J., Nechrebecki, M. M., Armstrong, E. A., Benavente, S., Gondi, V, Hsu, K.-T., & Harari, P. M. (2008) · Oncogene

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 550

The Role of Src in Solid Tumors

Wheeler, D. L., Iida, M., & Dunn, E. F. (2009) · The Oncologist

Cancer Mechanisms and TherapyProtein Kinase Regulation and GTPase Signaling

Cited by 346

Epidermal Growth Factor Receptor cooperates with Src Family Kinases in acquired resistance to cetuximab

Wheeler, D. L., Iida, M., Kruser, T. J., Nechrebecki, M. M., Dunn, E. F., Armstrong, E. A., Huang, S., & Harari, P. M. (2009) · Cancer Biology & Therapy

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 157

Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab

Dunn, E. F., Iida, M., Myers, R. A., Campbell, D. A., Hintz, K. A., Armstrong, E. A., Li, C., & Wheeler, D. L. (2011) · Oncogene

Colorectal Cancer Treatments and StudiesProtein Kinase Regulation and GTPase Signaling

Cited by 133